We have a formidable track record when it comes to turning world class research into globally adopted commercial opportunities, with our innovations contributing billions of dollars to the Australian economy annually.

Our team of IP and commercialisation experts help navigate the multifaceted commercialisation process, to maximise the impact of research. We provide tailored advice regarding intellectual property management, licensing, spin-outs and other commercialisation options. Large, complex, licensing and equity transactions are our speciality. Our licensing revenue is re-invested into the innovation eco-system, magnifying our impact and research into deep tech science.

Our commercialisation record:

As at 2018:

  • 697 patent families
  • 497 active licenses
  • 170+ companies started from CSIRO technology
  • $121M total value of CSIRO interest in portfolio companies

In 2018:

  • $43M in IP revenue
  • $48M in revenue generated by portfolio companies
  • $76M in capital raised by portfolio companies

Our equity portfolio

Supporting the growth of high-tech companies

Over 170 companies have been born from CSIRO technology. We currently hold equity interests in over 30 companies, who have a combined market capitalisation in excess of AUD$1 billion.

We have developed a number of commercialisation pathways to convert our IP into real outcomes and impact for Australia including licensing and assigning IP, research for equity as well as spin-outs and joint ventures.

Snapshot of our equity portfolio companies

Arista Cereal Technologies

Arista is a privately held, joint venture company formed by Limagrain, a fifty-year-old farmer-founded and directed, world player in wheat seeds, and CSIRO, a globally recognized organization focused on using science to make a positive difference in the world for nearly one hundred years. These 2 companies began collaborating on fundamental research in wheat starch 20 years ago, and joined their efforts and expertise in 2006 to create Arista, and develop a wheat with direct consumer health benefits.


Chrysos aims to deliver high quality, real-time analytical information and services to the global mining industry through its unique ChrysosTM PhotonAssay technology. In collaboration with national and international partners, the Adelaide-based company supports mining and mineral processing operations around the world by providing real-time, accurate and cost-effective information on ore grade without the laborious, time-consuming and error-prone sample preparation or the complex chemical treatment. Its technology, which has been developed by CSIRO over the past fifteen years, will provide true ‘atom-counting’ analysis, and report grade irrespective of the physical or chemical form of the material being measured.


NextOre is a joint venture between CSIRO, RFC Ambrian, and Advisian Digital. Sydney-based and proudly Australia, NextOre’s purpose is the deployment of innovative technologies into the mining and minerals processing worldwide. It proudly presents its Magnetic Resonance (MR) ore sorting technology in the form of MR sensors which are fitted over industry standard conveyor belts in order to provide near-instantaneous whole-of-ore grade estimates. These highly accurate, real-time measurements allow operations to divert waste material, resulting in higher grade and lower tonnage mill feed. The results are measurable efficiency improvements allowing mining companies to take action in improving environmental sustainability, site consumption, and unit costs.

Contact us

Your contact details

First name must be filled in

We'll need to know what you want to contact us about so we can give you an answer.